Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$42.05 - $47.77 $204,194 - $231,971
-4,856 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$40.23 - $47.74 $16,775 - $19,907
-417 Reduced 7.91%
4,856 $212,000
Q4 2021

Feb 14, 2022

SELL
$38.88 - $45.31 $30,754 - $35,840
-791 Reduced 13.04%
5,273 $233,000
Q3 2021

Nov 12, 2021

SELL
$38.79 - $43.16 $18,153 - $20,198
-468 Reduced 7.16%
6,064 $232,000
Q2 2021

Aug 16, 2021

BUY
$36.52 - $41.46 $5,039 - $5,721
138 Added 2.16%
6,532 $260,000
Q1 2021

May 14, 2021

BUY
$34.27 - $40.01 $342 - $400
10 Added 0.16%
6,394 $228,000
Q4 2020

Mar 03, 2021

BUY
$34.07 - $39.94 $10,357 - $12,141
304 Added 5.0%
6,384 $235,000
Q2 2020

Aug 14, 2020

BUY
$37.87 - $43.58 $1,931 - $2,222
51 Added 0.85%
6,080 $248,000
Q1 2020

May 15, 2020

SELL
$32.47 - $48.83 $4,610 - $6,933
-142 Reduced 2.3%
6,029 $228,000
Q4 2019

Feb 13, 2020

SELL
$42.0 - $48.25 $234,990 - $269,958
-5,595 Reduced 47.55%
6,171 $290,000
Q3 2019

Nov 13, 2019

BUY
$40.46 - $43.52 $121,015 - $130,168
2,991 Added 34.09%
11,766 $502,000
Q2 2019

Aug 13, 2019

SELL
$39.4 - $42.7 $6,579 - $7,130
-167 Reduced 1.87%
8,775 $351,000
Q1 2019

May 16, 2019

SELL
$38.57 - $42.69 $512,981 - $567,777
-13,300 Reduced 59.8%
8,942 $374,000
Q4 2018

Feb 13, 2019

SELL
$37.8 - $42.69 $62,596 - $70,694
-1,656 Reduced 6.93%
22,242 $866,000
Q3 2018

Nov 15, 2018

BUY
$39.75 - $42.69 $11,289 - $12,123
284 Added 1.2%
23,898 $960,000
Q2 2018

Aug 20, 2018

SELL
$39.61 - $42.76 $14,655 - $15,821
-370 Reduced 1.54%
23,614 $951,000
Q1 2018

May 16, 2018

SELL
$36.18 - $40.15 $165,812 - $184,007
-4,583 Reduced 16.04%
23,984 $937,000
Q4 2017

Feb 15, 2018

SELL
$35.34 - $41.9 $13,570 - $16,089
-384 Reduced 1.33%
28,567 $1.01 Million
Q3 2017

Nov 14, 2017

BUY
$39.44 - $41.55 $47,091 - $49,610
1,194 Added 4.3%
28,951 $1.18 Million
Q2 2017

Aug 15, 2017

BUY
N/A
27,757
27,757 $1.2 Million

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $67.3B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Laurel Wealth Advisors, Inc. Portfolio

Follow Laurel Wealth Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurel Wealth Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Laurel Wealth Advisors, Inc. with notifications on news.